InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Lynn Baxter, President, Europe. Director active across 1 companies, notably GSK plc. In total, 1 disclosures have been recorded. The latest transaction was filed on 12 May 2026 — Purchase. Regulator: RNS (LSE). The full history is free.
Declarations1 total
£25812 shares@ £21.51210.0000% mcap100.0% of flow
London Stock Exchange (XLON)
RNS:9569357-0·
Ideal exit: 6 Feb 2027 (T+270)
1 of 1 declaration
About Lynn Baxter
Lynn Baxter is the Chief Executive Officer of GSK plc, overseeing operations in Europe. With extensive experience in the pharmaceutical sector, she is responsible for the company's strategy and overall direction. Her leadership is crucial for growth and innovation within GSK, a leading health company. She is committed to promoting sustainable health solutions and addressing patient needs worldwide.
